Department of Community Health Medicine/Public Health Medicine, Sefako Makgatho Health Sciences University, Pretoria, South Africa.
Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, South Africa.
S Afr Med J. 2024 Aug 2;114(8):e1736. doi: 10.7196/SAMJ.2024.v114i8.1736.
South Africa (SA) has committed to eliminating malaria by 2028. However, the initial target was set for 2023. Additionally, the ongoing COVID-19 pandemic and the emergence of drug and insecticide resistance have been identified as potential stumbling blocks in the achievement of this goal. The impact of COVID-19 on the prevalence and distribution of malaria in SA is unclear.
To describe the trends and distribution of malaria before and during the pandemic and its associated lockdown strategies in one of the country's malaria-endemic provinces, Mpumalanga Province.
A descriptive, retrospective and cross-sectional study was conducted using Mpumalanga provincial malaria case data extracted from the provincial District Health Information System 2. The impact of COVID-19 on the prevalence and distribution of malaria was assessed in Mpumalanga Province between 2017 and 2022 using descriptive trend analysis. Malaria cases before (2017 - 2019) and post- COVID-19 (2020 - 2022) were cross-tabulated using Stata version 17. We used χ2 tests to test for significant differences, set at p<0.05.
During the study period, 25 380 malaria cases were reported, with the majority men (61%) >26 years old, with reported international travel, primarily to Mozambique. Limpopo Province (93%) accounted for most of the locally imported cases. Headaches and fever were the most common symptoms before and post COVID-19, while asymptomatic malaria carriage was higher during and post COVID (p<0.05). Prior to the pandemic reporting of the preferred treatment for uncomplicated malaria, Coartem use was at 53%, declining to 21% thereafter. Although COVID-19-related restrictions on human movement greatly reduced the malaria burden in Mpumalanga Province, the high-risk group (young mobile men) remained unchanged over the study period. Of concern were the marked reduction in the reporting of Coartem doses administered and the increased prevalence of asymptomatic carriage since 2020. The importation of malaria poses one of the biggest challenges to malaria elimination in Mpumalanga Province.
This study highlighted the impact of COVID-19 and its related lockdown restrictions on the delivery of malaria health services in Mpumalanga Province. If malaria elimination is to be achieved, all aspects of the malaria programme must be strengthened urgently. Additionally, the health system and cross-border collaborations must also be strengthened.
南非(SA)已承诺到 2028 年消除疟疾。然而,最初的目标设定在 2023 年。此外,持续的 COVID-19 大流行和抗药性的出现被认为是实现这一目标的潜在障碍。COVID-19 对 SA 疟疾的流行和分布的影响尚不清楚。
描述疟疾在大流行之前和期间的趋势和分布情况,以及在该国一个疟疾流行省份姆普马兰加省实施的相关封锁策略。
采用描述性、回顾性和横断面研究方法,使用从省级地区卫生信息系统 2 中提取的姆普马兰加省疟疾病例数据。使用描述性趋势分析评估 COVID-19 在 2017 年至 2022 年期间对姆普马兰加省疟疾流行和分布的影响。使用 Stata 版本 17 将 COVID-19 之前(2017-2019 年)和之后(2020-2022 年)的疟疾病例进行交叉制表。我们使用 χ2 检验来检验显著差异,设定为 p<0.05。
在研究期间,报告了 25380 例疟疾病例,大多数为男性(61%)>26 岁,有国际旅行记录,主要是前往莫桑比克。林波波省(93%)占大多数本地输入病例。头痛和发热是 COVID-19 前后最常见的症状,而无症状疟疾携带率在 COVID 期间和之后更高(p<0.05)。在大流行之前,报告的治疗无并发症疟疾的首选药物是 Coartem,使用率为 53%,此后降至 21%。尽管 COVID-19 相关的人类流动限制大大降低了姆普马兰加省的疟疾负担,但高风险人群(年轻流动男性)在研究期间保持不变。令人担忧的是,自 2020 年以来,Coartem 剂量的报告和无症状携带率的增加。疟疾的输入是姆普马兰加省消除疟疾的最大挑战之一。
本研究强调了 COVID-19 及其相关封锁限制对姆普马兰加省疟疾卫生服务提供的影响。如果要实现消除疟疾,必须紧急加强疟疾规划的各个方面。此外,还必须加强卫生系统和跨境合作。